Max Wilhelm
Novartis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Max Wilhelm.
European Journal of Pharmacology | 1977
Peter C. Waldmeier; Peter A. Baumann; Max Wilhelm; Raymond Bernasconi; L. Maitre
The effects of two new compounds, 1-(1-methylamino-2-hydroxy-3-propyl)-dibenzo[b,e]bicyclo[2,2,2]octadiene-HCl (C 49802-B-Ba) and 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A), on noradrenaline (NA) and serotonin (5-HT) uptake were investigated in different test systems, CGP 6085 A is a very potent and selective inhibitor of 5-HT uptake in rat brain (ED50 1-4 mg/kg p.o., depending on test system). Doses up to 1000 mg/kg p.o. did not inhibit NA uptake. C 49802-B-Ba is a potent and selective inhibitor of NA uptake in rat brain (ED50 5-10 mg/kg p.o. depending on test system) and heart (ED50 1.5 mg/kg p.o.). At 300 mg/kg p.o., this compound caused no inhibition of 5-HT uptake.
Archive | 1964
Heinrich Keberle; J. W. Faigle; Max Wilhelm
Archive | 1975
Max Wilhelm
Archive | 1968
Hans Ulrich Daeniker; Karl Schenker; Paul Schmidt; Max Wilhelm
Archive | 1965
Ernst Sury; Kurt Eichenberger; Max Wilhelm; Paul Schmidt
Archive | 1975
Max Wilhelm; Raymond Bernasconi; Angelo Storni; Dieter Beck; Karl Schenker
Archive | 1976
Max Wilhelm; Raymond Bernasconi; Angelo Storni; Dieter Beck; Karl Schenker
Archive | 1967
Paul Schmidt; Kurt Eichenberger; Alberto Rossi; Max Wilhelm
Archive | 1964
Hans Bickel; Rolf Bosshardt; Bruno Fechtig; Karl Schenker; Jakob Urech; Max Wilhelm
Archive | 1967
Karl Schenker; Ulrich Daeniker Hans; Paul Schmidt; Max Wilhelm
